4553.T

Towa Pharmaceutical Co Ltd · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$84.32B

PE Ratio

9.99786971038018

EV to Ebitda

—

Earnings Yield

1341425782.52%

Revenue (TTM)

$1.35B

Net Income (TTM)

$69.8M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

15.10%

Profit Margin

1.61%

Return on Equity

—

Debt to Equity Ratio

1.0748261073269183

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$84.32B

Revenue TTM$1.35B

Shares Outstanding49.2M

Float22524927

Insider Ownership47.95%

Institutional Ownership18.39%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)15.10%

Rev Growth Est 1Y Forward0.6450

EPS Growth (Quarterly YoY)-66.30%

EPS Growth Est Quarterly0

LT EPS Growth Estimates-12.00%

Operations14 fields›

Revenue TTM$1.35B

Gross Margin TTM38.90%

Gross Margin (Quarterly)36.58%

Operating Margin TTM3.82%

Operating Margin (Quarterly)2.84%

Profit Margin TTM1.61%

Profit Margin (Quarterly)2.87%

Net Income TTM$69.8M

EPS TTM186.01

EBIT Margin TTM10.11%

EBITDA TTM$136.1M

Capex % of Revenue TTM7.53%

Capital Expenditures$101.2M

FCF % of Revenue (Quarterly)4.74%

Efficiency1 fields›

ROA1.41%

Valuation7 fields›

P/E (TTM)9.99786971038018

P/E Forward8.1699

EV/Revenues (TTM)1.2698

Price To Book0.67481206593866

Earnings Yield1341425782.52%

Dividend Yield0.00%

Payout Ratio116.54%

Liquidity8 fields›

Cash Per Share639.5946368811035

Current Ratio1.4500708246069887

Goodwill & Intangibles$56833.00T

Total Assets$351659.00T

Total Liabilities$5.44B

Shareholders Equity$138735.00T

Debt to Equity1.0748261073269183

Interest Expense$492.0M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio116.54%

Earnings Yield1341425782.52%